{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:12:30Z","timestamp":1787026350498,"version":"build-2736575974"},"reference-count":143,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:p>\n                    Severe Fever with Thrombocytopenia Syndrome (SFTS), caused by the SFTS virus (SFTSV), is a tick-borne disease that poses a significant public health threat due to its high fatality rate and the lack of effective treatments or vaccines. Since its first identification, SFTSV has been reported in multiple countries, including China, South Korea, Japan, and Vietnam, highlighting its expanding regional footprint and potential global impact. This review summarizes recent preclinical and early clinical advancements in vaccine development and therapeutic strategies for SFTSV, with an emphasis on novel vaccine platforms and antiviral approaches. It also discusses the critical role of immunocompromised animal models, such as IFNAR\n                    <jats:sup>\u2013<\/jats:sup>\n                    \/\n                    <jats:sup>\u2013<\/jats:sup>\n                    and STAT2\n                    <jats:sup>\u2013<\/jats:sup>\n                    \/\n                    <jats:sup>\u2013<\/jats:sup>\n                    mice, in elucidating disease mechanisms and evaluating candidate interventions. Promising vaccine platforms include mRNA-based vaccines, viral vector vaccines, protein subunit vaccines, and inactivated virus vaccines. Additionally, therapeutic approaches\u2014such as RNA-dependent RNA polymerase (RdRp) inhibitors, calcium channel blockers, immunotherapies, targeted therapeutic strategies, and traditional Chinese medicine\u2014have demonstrated potential in preclinical and limited clinical studies. However, challenges remain, including reduced efficacy when treatment is administered late, limited validation in human clinical trials, and the risk of viral resistance. Despite progress, key challenges persist in modeling human SFTS in animals and translating preclinical findings to clinical applications. This review underscores the urgent need for continued research to address these gaps, accelerate the development of effective countermeasures, and enhance global preparedness for future SFTSV outbreaks.\n                  <\/jats:p>","DOI":"10.3389\/fcimb.2025.1650652","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T10:07:32Z","timestamp":1758622052000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Advancements in vaccine development and therapeutic approaches for severe fever with Thrombocytopenia Syndrome"],"prefix":"10.3389","volume":"15","author":[{"given":"Tsenddari","family":"Ganbold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satabdi","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunirmal","family":"Sheet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enkhtsatsral","family":"Munkhtur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Tshool","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1238882","article-title":"CCHFV vaccine development, current challenges, limitations, and future directions","volume":"14","author":"Ahata","year":"2023","journal-title":"Front. Immunol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/2040206617740303","article-title":"Establishment of an antiviral assay system and identification of severe fever with thrombocytopenia syndrome virus inhibitors","volume":"25","author":"Baba","year":"2017","journal-title":"Antiviral Chem. Chemotherapy."},{"key":"B3","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"New Engl. J. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.molcel.2017.05.028","article-title":"Intracellular Ca2+ sensing: its role in calcium homeostasis and signaling","volume":"66","author":"Bagur","year":"2017","journal-title":"Mol. Cell."},{"key":"B5","doi-asserted-by":"publisher","first-page":"9458","DOI":"10.1073\/pnas.1233578100","article-title":"Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses","volume":"100","author":"Belyakov","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00743-17","article-title":"Mapping of transcription termination within the S segment of SFTS phlebovirus facilitated generation of NSs deletant viruses","volume":"91","author":"Brennan","year":"2017","journal-title":"J. virology."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2014.11.010","article-title":"A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs","volume":"114","author":"Cao","year":"2015","journal-title":"Antiviral Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s12276-021-00610-1","article-title":"Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy","volume":"53","author":"Casel","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008453","article-title":"Severe fever with thrombocytopenia syndrome virus infection during pregnancy in C57\/BL6 mice causes fetal damage","volume":"14","author":"Chen","year":"2020","journal-title":"PloS Negl. Trop. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1099\/vir.0.041053-0","article-title":"Infection and pathogenesis of Huaiyangshan virus (a novel tick-borne bunyavirus) in laboratory rodents","volume":"93","author":"Chen","year":"2012","journal-title":"J. Gen. Virol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"21831","DOI":"10.1038\/s41598-021-01361-9","article-title":"Estimating severe fever with thrombocytopenia syndrome transmission using machine learning methods in South Korea","volume":"11","author":"Cho","year":"2021","journal-title":"Sci. Rep."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01684-19","article-title":"Severe fever with thrombocytopenia syndrome virus NSs interacts with TRIM21 to activate the p62-Keap1-Nrf2 pathway","volume":"94","author":"Choi","year":"2020","journal-title":"J. virology."},{"key":"B13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41564-018-0329-x","article-title":"Severe fever with thrombocytopenia syndrome phlebovirus non-structural protein activates TPL2 signalling pathway for viral immunopathogenesis","volume":"4","author":"Choi","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"3736201","DOI":"10.1155\/2017\/3736201","article-title":"Safety of human papillomavirus 9-valent vaccine: a meta-analysis of randomized trials","volume":"2017","author":"Costa","year":"2017","journal-title":"J. Immunol. Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/2051013615595595","article-title":"Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults","volume":"3","author":"Cox","year":"2015","journal-title":"Ther. Adv. Vaccines"},{"key":"B16","doi-asserted-by":"publisher","first-page":"20199","DOI":"10.1038\/s41598-019-56481-0","article-title":"In vivo activity of amodiaquine against Ebola virus infection","volume":"9","author":"DeWald","year":"2019","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1586\/17469899.3.1.97","article-title":"Ocular toxicity of fludarabine: a purine analog","volume":"3","author":"Ding","year":"2008","journal-title":"Expert Rev. ophthalmology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41541-018-0096-y","article-title":"Single dose of a rVSV-based vaccine elicits complete protection against severe fever with thrombocytopenia syndrome virus","volume":"4","author":"Dong","year":"2019","journal-title":"NPJ Vaccines"},{"key":"B19","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1038\/s41467-023-41804-7","article-title":"Cryo-EM structure of severe fever with thrombocytopenia syndrome virus","volume":"14","author":"Du","year":"2023","journal-title":"Nat. Commun."},{"key":"B20","doi-asserted-by":"publisher","first-page":"11307","DOI":"10.1128\/JVI.01460-09","article-title":"Mutational analysis of the Bunyamwera orthobunyavirus nucleocapsid protein gene","volume":"83","author":"Eifan","year":"2009","journal-title":"J. virology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.antiviral.2015.03.005","article-title":"Evaluation of Crimean-Congo hemorrhagic fever virus in vitro inhibition by chloroquine and chlorpromazine, two FDA approved molecules","volume":"118","author":"Ferraris","year":"2015","journal-title":"Antiviral Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.antiviral.2009.02.198","article-title":"T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections","volume":"82","author":"Furuta","year":"2009","journal-title":"Antiviral Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"774","DOI":"10.3390\/v13050774","article-title":"Fludarabine inhibits infection of Zika virus, SFTS phlebovirus, and Enterovirus A71","volume":"13","author":"Gao","year":"2021","journal-title":"Viruses."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2024.106181","article-title":"Effect of tocilizumab plus corticosteroid on clinical outcome in patients hospitalized with severe fever with thrombocytopenia syndrome: A randomized clinical trial","volume":"89","author":"Ge","year":"2024","journal-title":"J. Infection"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1093\/jac\/dku091","article-title":"The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry","volume":"69","author":"Gehring","year":"2014","journal-title":"J. Antimicrobial Chemotherapy."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01942-16","article-title":"Modeling severe fever with thrombocytopenia syndrome virus infection in golden Syrian hamsters: importance of STAT2 in preventing disease and effective treatment with favipiravir","volume":"91","author":"Gowen","year":"2017","journal-title":"J. virology."},{"key":"B27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/rmv.483","article-title":"Mechanisms of action of ribavirin against distinct viruses","volume":"16","author":"Graci","year":"2006","journal-title":"Rev. Med. virology."},{"key":"B28","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.scr.2016.08.013","article-title":"Advantages of nonhuman primates as preclinical models for evaluating stem cell-based therapies for Parkinson\u2019s disease","volume":"17","author":"Grow","year":"2016","journal-title":"Stem Cell Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/jmv.25031","article-title":"The antimalarial drug amodiaquine possesses anti-ZIKA virus activities","volume":"90","author":"Han","year":"2018","journal-title":"J. Med. virology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4231","DOI":"10.1016\/j.vaccine.2022.05.081","article-title":"Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys","volume":"40","author":"Hashimoto","year":"2022","journal-title":"Vaccine."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1056\/NEJMoa2107659","article-title":"Safety and efficacy of NVX-coV2373 covid-19 vaccine","volume":"385","author":"Heath","year":"2021","journal-title":"New Engl. J. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1128\/AAC.14.5.690","article-title":"Evaluation of virucidal compounds for inactivation of rhinovirus on hands","volume":"14","author":"Hendley","year":"1978","journal-title":"Antimicrobial Agents Chemotherapy."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4384","DOI":"10.1128\/JVI.02628-12","article-title":"Severe fever with thrombocytopenia virus glycoproteins are targeted by neutralizing antibodies and can use DC-SIGN as a receptor for pH-dependent entry into human and animal cell lines","volume":"87","author":"Hofmann","year":"2013","journal-title":"J. virology."},{"key":"B34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.febslet.2004.08.015","article-title":"Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV","volume":"574","author":"Hsu","year":"2004","journal-title":"FEBS Lett."},{"key":"B35","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.1128\/JVI.00672-13","article-title":"Structure of severe fever with thrombocytopenia syndrome virus nucleocapsid protein in complex with suramin reveals therapeutic potential","volume":"87","author":"Jiao","year":"2013","journal-title":"J. virology."},{"key":"B36","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/infdis\/jiu564","article-title":"SFTS virus infection in nonhuman primates","volume":"211","author":"Jin","year":"2015","journal-title":"J. Infect. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"10053","DOI":"10.1073\/pnas.1120246109","article-title":"Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57\/BL6 mouse model","volume":"109","author":"Jin","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jiac.2017.10.016","article-title":"A patient with severe fever with thrombocytopenia syndrome and hemophagocytic lymphohistiocytosis-associated involvement of the central nervous system","volume":"24","author":"Kaneko","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007813","article-title":"Vaccination with single plasmid DNA encoding IL-12 and antigens of severe fever with thrombocytopenia syndrome virus elicits complete protection in IFNAR knockout mice","volume":"14","author":"Kang","year":"2020","journal-title":"PloS Negl. Trop. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"356","DOI":"10.7883\/yoken.JJID.2018.526","article-title":"A case of cat-to-human transmission of severe fever with thrombocytopenia syndrome virus","volume":"72","author":"Kida","year":"2019","journal-title":"Jpn J. Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1038\/s41541-023-00771-2","article-title":"mRNA vaccine encoding Gn provides protection against severe fever with thrombocytopenia syndrome virus in mice","volume":"8","author":"Kim","year":"2023","journal-title":"NPJ Vaccines"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007375","article-title":"An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus","volume":"15","author":"Kim","year":"2019","journal-title":"PloS pathogens."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.29203","article-title":"SFTSV Gn-Head mRNA vaccine confers efficient protection against lethal viral challenge","volume":"95","author":"Kim","year":"2023","journal-title":"J. Med. Virology."},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1452739","article-title":"Limitations of a proper SFTSV mouse model using human C-type lectin receptors","volume":"15","author":"Kim","year":"2024","journal-title":"Front. Microbiol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.3201\/eid1911.130792","article-title":"Severe fever with thrombocytopenia syndrome, South Korea, 2012","volume":"19","author":"Kim","year":"2013","journal-title":"Emerging Infect. diseases."},{"key":"B46","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/j.1552-4604.1973.tb00196.x","article-title":"Review of the toxicity of hexachlorophene, including its neurotoxicity","volume":"13","author":"Kimbrough","year":"1973","journal-title":"J. Clin. Pharmacol. New Drugs"},{"key":"B47","doi-asserted-by":"publisher","first-page":"692","DOI":"10.3201\/eid2604.191011","article-title":"Severe fever with thrombocytopenia syndrome, Japan, 2013-2017","volume":"26","author":"Kobayashi","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S1473-3099(20)30248-6","article-title":"Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial","volume":"20","author":"Koch","year":"2020","journal-title":"Lancet Infect. Diseases."},{"key":"B49","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/01.mcg.0000145494.76305.11","article-title":"Hematologic side effects of interferon and ribavirin therapy","volume":"39","author":"Kowdley","year":"2005","journal-title":"J. Clin. gastroenterology."},{"key":"B50","doi-asserted-by":"publisher","first-page":"695","DOI":"10.3390\/vaccines11030695","article-title":"The integrated consideration of vaccine platforms, adjuvants, and delivery routes for successful vaccine development","volume":"11","author":"Kozak","year":"2023","journal-title":"Vaccines."},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.204.Supp.167.33","article-title":"Development of a DNA vaccine for SFTSV that confers complete protection against lethal infection in ferrets","volume":"204","author":"Kwak","year":"2020","journal-title":"J. Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1182\/blood-2017-03-754119","article-title":"Clinical updates in adult immune thrombocytopenia","volume":"129","author":"Lambert","year":"2017","journal-title":"Blood J. Am. Soc. Hematology."},{"key":"B53","doi-asserted-by":"publisher","first-page":"204ra131","DOI":"10.1126\/scitranslmed.3006827","article-title":"siRNA screen for genes that affect Junin virus entry uncovers voltage-gated calcium channels as a therapeutic target","volume":"5","author":"Lavanya","year":"2013","journal-title":"Sci. Trans. Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"731","DOI":"10.3904\/kjim.2016.109","article-title":"In vitro antiviral activity of ribavirin against severe fever with thrombocytopenia syndrome virus","volume":"32","author":"Lee","year":"2016","journal-title":"Korean J. Internal Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"51","DOI":"10.4110\/in.2015.15.2.51","article-title":"Recent advances of vaccine adjuvants for infectious diseases","volume":"15","author":"Lee","year":"2015","journal-title":"Immune Netw."},{"key":"B56","doi-asserted-by":"publisher","first-page":"21172","DOI":"10.1038\/s41598-023-46233-6","article-title":"Safety, immunogenicity and efficacy of an mRNA-based COVID-19 vaccine, GLB-COV2-043, in preclinical animal models","volume":"13","author":"Lelis","year":"2023","journal-title":"Sci. Rep."},{"key":"B57","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.molimm.2021.04.010","article-title":"Non-human primate models of human respiratory infections","volume":"135","author":"Lemaitre","year":"2021","journal-title":"Mol. Immunol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1038\/sj.thj.6200387","article-title":"Role of fludarabine as monotherapy in the treatment of chronic lymphocytic leukemia","volume":"5","author":"Leporrier","year":"2004","journal-title":"Hematol. J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bsheal.2021.12.008","article-title":"Immunogenicity and protective efficacy of an inactivated SFTS vaccine candidate in mice","volume":"4","author":"Li","year":"2022","journal-title":"Biosaf Health"},{"key":"B60","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41392-021-00541-3","article-title":"Clinical effect and antiviral mechanism of T-705 in treating severe fever with thrombocytopenia syndrome","volume":"6","author":"Li","year":"2021","journal-title":"Signal transduction targeted Ther."},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aat4162","article-title":"Arginine deficiency is involved in thrombocytopenia and immunosuppression in severe fever with thrombocytopenia syndrome","volume":"10","author":"Li","year":"2018","journal-title":"Sci. Trans. Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/s41422-019-0214-z","article-title":"Calcium channel blockers reduce severe fever with thrombocytopenia syndrome virus (SFTSV) related fatality","volume":"29","author":"Li","year":"2019","journal-title":"Cell Res."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21634-1","article-title":"S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates","volume":"12","author":"Liang","year":"2021","journal-title":"Nat. Commun."},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01575-19","article-title":"The severe fever with thrombocytopenia syndrome virus NSs protein interacts with CDK1 to induce G2 cell cycle arrest and positively regulate viral replication","volume":"94","author":"Liu","year":"2020","journal-title":"J. Virology."},{"key":"B65","doi-asserted-by":"publisher","first-page":"199149","DOI":"10.1016\/j.virusres.2023.199149","article-title":"Investigation of a subunit protein vaccine for HFRS based on a consensus sequence between envelope glycoproteins of HTNV and SEOV","volume":"334","author":"Liu","year":"2023","journal-title":"Virus Res."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1128\/JVI.02277-13","article-title":"The pathogenesis of severe fever with thrombocytopenia syndrome virus infection in alpha\/beta interferon knockout mice: insights into the pathologic mechanisms of a new viral hemorrhagic fever","volume":"88","author":"Liu","year":"2014","journal-title":"J. Virol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/1744-9987.12240","article-title":"Evaluation of plasma exchange and continuous veno-venous hemofiltration for the treatment of severe avian influenza a (H7N9): a cohort study","volume":"19","author":"Liu","year":"2015","journal-title":"Ther. Apheresis Dialysis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0140-6736(20)31866-3","article-title":"Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1\/2 studies from Russia","volume":"396","author":"Logunov","year":"2020","journal-title":"Lancet."},{"key":"B69","doi-asserted-by":"publisher","first-page":"22977","DOI":"10.1038\/s41598-021-01985-x","article-title":"Subcellular localization of nucleocapsid protein of SFTSV and its assembly into the ribonucleoprotein complex with L protein and viral RNA","volume":"11","author":"Lokupathirage","year":"2021","journal-title":"Sci. Rep."},{"key":"B70","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.chom.2011.06.007","article-title":"DC-SIGN as a receptor for phleboviruses","volume":"10","author":"Lozach","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011060","article-title":"The mechanism of genome replication and transcription in bunyaviruses","volume":"19","author":"Malet","year":"2023","journal-title":"PloS Pathogens."},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00104","article-title":"Animal models of emerging tick-borne phleboviruses: determining target cells in a lethal model of SFTSV infection","volume":"8","author":"Matsuno","year":"2017","journal-title":"Front. Microbiol."},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/v14020223","article-title":"Suspected transmission of severe fever with thrombocytopenia syndrome virus from a cat to a veterinarian by a single contact: A case report","volume":"14","author":"Miyauchi","year":"2022","journal-title":"Viruses-Basel"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009129","article-title":"Host restriction of emerging high-pathogenic bunyaviruses via MOV10 by targeting viral nucleoprotein and blocking ribonucleoprotein assembly","volume":"16","author":"Mo","year":"2020","journal-title":"PloS Pathog."},{"key":"B75","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1021\/jm00303a605","article-title":"Nucleosides of 2-fluoroadenine","volume":"12","author":"Montgomery","year":"1969","journal-title":"J. medicinal Chem."},{"key":"B76","doi-asserted-by":"publisher","first-page":"11873","DOI":"10.1128\/JVI.79.18.11873-11891.2005","article-title":"An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection","volume":"79","author":"Morikawa","year":"2005","journal-title":"J. virology."},{"key":"B77","doi-asserted-by":"publisher","first-page":"5490","DOI":"10.3390\/molecules26185490","article-title":"Caffeic acid on metabolic syndrome: A review","volume":"26","author":"Muhammad Abdul Kadar","year":"2021","journal-title":"Molecules."},{"key":"B78","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.jiac.2017.11.004","article-title":"Steroid pulse therapy in patients with encephalopathy associated with severe fever with thrombocytopenia syndrome","volume":"24","author":"Nakamura","year":"2018","journal-title":"J. infection chemotherapy."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01182","article-title":"Interferon-\u03b3-directed inhibition of a novel high-pathogenic phlebovirus and viral antagonism of the antiviral signaling by targeting STAT1","volume":"10","author":"Ning","year":"2019","journal-title":"Front. Immunol."},{"key":"B80","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jiac.2018.03.005","article-title":"Caffeic acid, a coffee-related organic acid, inhibits infection by severe fever with thrombocytopenia syndrome virus in vitro","volume":"24","author":"Ogawa","year":"2018","journal-title":"J. infection chemotherapy"},{"key":"B81","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jiac.2020.10.015","article-title":"Structural basis of antiviral activity of caffeic acid against severe fever with thrombocytopenia syndrome virus","volume":"27","author":"Ogawa","year":"2021","journal-title":"J. Infection Chemotherapy."},{"key":"B82","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ijid.2013.08.011","article-title":"Plasma exchange and ribavirin for rapidly progressive severe fever with thrombocytopenia syndrome","volume":"18","author":"Oh","year":"2014","journal-title":"Int. J. Infect. Diseases."},{"key":"B83","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines\u2014a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug discovery."},{"key":"B84","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B85","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/s41564-018-0317-1","article-title":"Ferret animal model of severe fever with thrombocytopenia syndrome phlebovirus for human lethal infection and pathogenesis","volume":"4","author":"Park","year":"2019","journal-title":"Nat. Microbiol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-3773-1","article-title":"Severe fever with thrombocytopenia syndrome: comparison with scrub typhus and clinical diagnostic prediction","volume":"19","author":"Park","year":"2019","journal-title":"BMC Infect. diseases."},{"key":"B87","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s42826-020-00070-0","article-title":"Pathogenicity of severe fever with thrombocytopenia syndrome virus in mice regulated in type I interferon signaling: Severe fever with thrombocytopenia and type I interferon","volume":"36","author":"Park","year":"2020","journal-title":"Lab. Anim. Res."},{"key":"B88","doi-asserted-by":"publisher","first-page":"11990","DOI":"10.1038\/s41598-019-48317-8","article-title":"Severe Fever with Thrombocytopenia Syndrome Phlebovirus causes lethal viral hemorrhagic fever in cats","volume":"9","author":"Park","year":"2019","journal-title":"Sci. Rep."},{"key":"B89","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3390\/v12090958","article-title":"A model for the production of regulatory grade viral hemorrhagic fever exposure stocks: from field surveillance to advanced characterization of SFTSV","volume":"12","author":"Perez-Sautu","year":"2020","journal-title":"Viruses."},{"key":"B90","doi-asserted-by":"publisher","first-page":"105127","DOI":"10.1016\/j.antiviral.2021.105127","article-title":"Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues","volume":"193","author":"Persoons","year":"2021","journal-title":"Antiviral Res."},{"key":"B91","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","article-title":"Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases","volume":"23","author":"Rainsford","year":"2015","journal-title":"Inflammopharmacology."},{"key":"B92","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.coviro.2018.03.005","article-title":"Current status of severe fever with thrombocytopenia syndrome vaccine development","volume":"29","author":"Reece","year":"2018","journal-title":"Curr. Opin. virology."},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104138","article-title":"Safety and immunogenicity of intramuscular, single-dose V590 (rVSV-SARS-CoV-2 Vaccine) in healthy adults: Results from a phase 1 randomised, double-blind, placebo-controlled, dose-ranging trial","volume":"82","author":"Robbins","year":"2022","journal-title":"EBioMedicine"},{"key":"B94","doi-asserted-by":"publisher","first-page":"7755","DOI":"10.1038\/s41598-019-44210-6","article-title":"Vesicular stomatitis virus-based vaccine protects mice against Crimean-Congo hemorrhagic fever","volume":"9","author":"Rodriguez","year":"2019","journal-title":"Sci. Rep."},{"key":"B95","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.cmi.2024.03.028","article-title":"Intradermal delivery of the third dose of the mRNA-1273 SARS-CoV-2 vaccine: safety and immunogenicity of a fractional booster dose","volume":"30","author":"Roozen","year":"2024","journal-title":"Clin. Microbiol. Infection."},{"key":"B96","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4278","article-title":"mRNA-based therapeutics - developing a new class of drugs","volume":"13","author":"Sahin","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"B97","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1093\/ajhp\/zxab043","article-title":"Acute and severe ribavirin-associated hyperuricemia and acute kidney injury: an underrecognized adverse effect","volume":"78","author":"Sakran","year":"2021","journal-title":"Am. J. Health-System Pharmacy."},{"key":"B98","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1126\/science.1258758","article-title":"Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment","volume":"347","author":"Sakurai","year":"2015","journal-title":"Science."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1139\/m83-225","article-title":"Rotavirus inactivation by chemical disinfectants and antiseptics used in hospitals","volume":"29","author":"Sattar","year":"1983","journal-title":"Can. J. Microbiol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.antiviral.2012.07.012","article-title":"A screen for modulators of large T antigen\u2019s ATPase activity uncovers novel inhibitors of Simian Virus 40 and BK virus replication","volume":"96","author":"Seguin","year":"2012","journal-title":"Antiviral Res."},{"key":"B101","doi-asserted-by":"publisher","first-page":"e82299","DOI":"10.1371\/journal.pone.0082299","article-title":"Inhibitory effects of caffeic acid phenethyl ester derivatives on replication of hepatitis C virus","volume":"8","author":"Shen","year":"2013","journal-title":"PloS One"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-015-0412-3","article-title":"Combination effects of ribavirin and interferons on severe fever with thrombocytopenia syndrome virus infection","volume":"12","author":"Shimojima","year":"2015","journal-title":"Virol. J."},{"key":"B103","doi-asserted-by":"publisher","first-page":"423","DOI":"10.7883\/yoken.67.423","article-title":"Effects of ribavirin on severe fever with thrombocytopenia syndrome virus in vitro","volume":"67","author":"Shimojima","year":"2014","journal-title":"Japanese J. Infect. Dis."},{"key":"B104","doi-asserted-by":"publisher","first-page":"107512","DOI":"10.1016\/j.pharmthera.2020.107512","article-title":"Favipiravir, an anti-influenza drug against life-threatening RNA virus infections","volume":"209","author":"Shiraki","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"B105","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.antiviral.2018.10.013","article-title":"2B-Fluoro-2\u2032-deoxycytidine is a broad-spectrum inhibitor of bunyaviruses in vitro and in phleboviral disease mouse models","volume":"160","author":"Smee","year":"2018","journal-title":"Antiviral Res."},{"key":"B106","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s15010-019-01364-9","article-title":"Severe fever with thrombocytopenia syndrome (SFTS) treated with a novel antiviral medication, favipiravir (T-705)","volume":"48","author":"Song","year":"2020","journal-title":"Infection."},{"key":"B107","doi-asserted-by":"publisher","first-page":"e0009103","DOI":"10.1371\/journal.pntd.0009103","article-title":"A multicenter non-randomized, uncontrolled single arm trial for evaluation of the efficacy and the safety of the treatment with favipiravir for patients with severe fever with thrombocytopenia syndrome","volume":"15","author":"Suemori","year":"2021","journal-title":"PloS Negl. Trop. diseases."},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.797189","article-title":"Animal model of severe fever with thrombocytopenia syndrome virus infection","volume":"12","author":"Sun","year":"2022","journal-title":"Front. Microbiol."},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00061-15","article-title":"Efficacy of T-705 (Favipiravir) in the treatment of infections with lethal severe fever with thrombocytopenia syndrome virus","volume":"1","author":"Tani","year":"2016","journal-title":"MSphere."},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3390\/v13020204","article-title":"Pathological characteristics of a patient with severe fever with thrombocytopenia syndrome (SFTS) infected with SFTS virus through a sick cat\u2019s bite","volume":"13","author":"Tsuru","year":"2021","journal-title":"Viruses-Basel"},{"key":"B111","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2169\/internalmedicine.7075-21","article-title":"Plasma exchange did not reduce viral load in a recovered case of severe fever with thrombocytopenia syndrome","volume":"61","author":"Utsunomiya","year":"2022","journal-title":"Internal Med."},{"key":"B112","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/vaccines4020012","article-title":"Recent advances in subunit vaccine carriers","volume":"4","author":"Vartak","year":"2016","journal-title":"Vaccines."},{"key":"B113","doi-asserted-by":"publisher","first-page":"5749","DOI":"10.1093\/nar\/gkaa253","article-title":"Structural and functional characterization of the severe fever with thrombocytopenia syndrome virus L protein","volume":"48","author":"Vogel","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"B114","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1099\/vir.0.024240-0","article-title":"Amino acid changes within the Bunyamwera virus nucleocapsid protein differentially affect the mRNA transcription and RNA replication activities of assembled ribonucleoprotein templates","volume":"92","author":"Walter","year":"2011","journal-title":"J. Gen. virology."},{"key":"B115","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.antiviral.2009.05.002","article-title":"Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro","volume":"83","author":"Wang","year":"2009","journal-title":"Antiviral Res."},{"key":"B116","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.celrep.2019.12.020","article-title":"The cap-snatching SFTSV endonuclease domain is an antiviral target","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Rep."},{"key":"B117","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3390\/pathogens8040158","article-title":"Vascular leak and hypercytokinemia associated with severe fever with thrombocytopenia syndrome virus infection in mice","volume":"8","author":"Westover","year":"2019","journal-title":"Pathogens."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1093\/nar\/gkac1249","article-title":"Structural insights into viral genome replication by the severe fever with thrombocytopenia syndrome virus L protein","volume":"51","author":"Williams","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1016\/j.vaccine.2014.05.052","article-title":"A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis","volume":"32","author":"Wu","year":"2014","journal-title":"Vaccine."},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136855","article-title":"A single-domain antibody inhibits SFTSV and mitigates virus-induced pathogenesis in vivo","volume":"5","author":"Wu","year":"2020","journal-title":"JCI Insight"},{"key":"B121","doi-asserted-by":"publisher","first-page":"E7564","DOI":"10.1073\/pnas.1705176114","article-title":"Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope","volume":"114","author":"Wu","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02246-17","article-title":"RIG-I-like receptor and toll-like receptor signaling pathways cause aberrant production of inflammatory cytokines\/chemokines in a severe fever with thrombocytopenia syndrome virus infection mouse model","volume":"92","author":"Yamada","year":"2018","journal-title":"J. Virol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.3201\/eid2612.191513","article-title":"Direct transmission of severe fever with thrombocytopenia syndrome virus from domestic cat to veterinary personnel","volume":"26","author":"Yamanaka","year":"2020","journal-title":"Emerg. Infect. Dis."},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.711847","article-title":"IL-6 and IL-10 levels, rather than viral load and neutralizing antibody titers, determine the fate of patients with severe fever with thrombocytopenia syndrome virus infection in South Korea","volume":"12","author":"Yoo","year":"2021","journal-title":"Front. Immunol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3904\/kjim.2016.194","article-title":"Application of therapeutic plasma exchange in patients having severe fever with thrombocytopenia syndrome","volume":"34","author":"Yoo","year":"2017","journal-title":"Korean J. Internal Med."},{"key":"B126","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ijid.2022.06.058","article-title":"Tocilizumab therapy for IL-6 increment in a patient with non-fatal severe fever with thrombocytopenia syndrome","volume":"122","author":"Yoo","year":"2022","journal-title":"Int. J. Infect. Dis."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02226-18","article-title":"Species-specific pathogenicity of severe fever with thrombocytopenia syndrome virus is determined by anti-STAT2 activity of NSs","volume":"93","author":"Yoshikawa","year":"2019","journal-title":"J. virology."},{"key":"B128","doi-asserted-by":"publisher","first-page":"e1008859","DOI":"10.1371\/journal.ppat.1008859","article-title":"A highly attenuated vaccinia virus strain LC16m8-based vaccine for severe fever with thrombocytopenia syndrome","volume":"17","author":"Yoshikawa","year":"2021","journal-title":"PloS Pathogens."},{"key":"B129","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","article-title":"Fever with thrombocytopenia associated with a novel bunyavirus in China","volume":"364","author":"Yu","year":"2011","journal-title":"N Engl. J. Med."},{"key":"B130","doi-asserted-by":"publisher","first-page":"e0012411","DOI":"10.1371\/journal.pntd.0012411","article-title":"Recent research advances in the development of Dabie Banda virus vaccines","volume":"18","author":"Yu","year":"2024","journal-title":"PloS Negl. Trop. Diseases."},{"key":"B131","doi-asserted-by":"publisher","first-page":"26900","DOI":"10.1073\/pnas.1914704116","article-title":"Cross-genotype protection of live-attenuated vaccine candidate for severe fever with thrombocytopenia syndrome virus in a ferret model","volume":"116","author":"Yu","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"key":"B132","doi-asserted-by":"publisher","first-page":"385","DOI":"10.3390\/v11040385","article-title":"Screening of an FDA-approved drug library with a two-tier system identifies an entry inhibitor of severe fever with thrombocytopenia syndrome virus","volume":"11","author":"Yuan","year":"2019","journal-title":"Viruses."},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.129531","article-title":"Genetic and pathogenic diversity of severe fever with thrombocytopenia syndrome virus SFTSV in South Korea","volume":"5","author":"Yun","year":"2020","journal-title":"JCI Insight"},{"key":"B134","doi-asserted-by":"crossref","DOI":"10.1080\/21505594.2021.1972201","article-title":"Roborovski hamster strain SH101 as a systemic infection model of SARS-CoV-2","volume":"12","author":"Zhai","year":"2021","journal-title":"Virulence"},{"key":"B135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106973","article-title":"Oral delivery of a host-directed antiviral, niclosamide, as a cholate-coated nanoformulation","volume":"62","author":"Zhai","year":"2023","journal-title":"Int. J. Antimicrob. Ag."},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00594","article-title":"Advances in mRNA vaccines for infectious diseases","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Immunol."},{"key":"B137","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1002\/jmv.26544","article-title":"Severe fever with thrombocytopenia syndrome in Hefei: Clinical features, risk factors, and ribavirin therapeutic efficacy","volume":"93","author":"Zhang","year":"2021","journal-title":"J. Med. Virology."},{"key":"B138","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41541-024-00991-0","article-title":"A comprehensive investigation of Glycoprotein-based nucleic acid vaccines for Hantaan Virus","volume":"9","author":"Zhang","year":"2024","journal-title":"NPJ Vaccines"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceca.2009.05.005","article-title":"Viral calciomics: interplays between Ca2+ and virus","volume":"46","author":"Zhou","year":"2009","journal-title":"Cell calcium."},{"key":"B140","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1016\/j.vaccine.2006.01.059","article-title":"A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice","volume":"24","author":"Zhou","year":"2006","journal-title":"Vaccine."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial","volume":"395","author":"Zhu","year":"2020","journal-title":"Lancet."},{"key":"B142","doi-asserted-by":"publisher","first-page":"868","DOI":"10.3201\/eid2405.151435","article-title":"Transmission of severe fever with thrombocytopenia syndrome virus by Haemaphysalis longicornis ticks, China","volume":"24","author":"Zhuang","year":"2018","journal-title":"Emerging Infect. Diseases."},{"key":"B143","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3390\/nu13020554","article-title":"Caffeic acid modulates processes associated with intestinal inflammation","volume":"13","author":"Zieli\u0144ska","year":"2021","journal-title":"Nutrients."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1650652\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T10:07:33Z","timestamp":1758622053000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2025.1650652\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":143,"alternative-id":["10.3389\/fcimb.2025.1650652"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2025.1650652","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"article-number":"1650652"}}